Partnership
Recipharm and PLG Announce Strategic Partnership to Accelerate Development Projects
Recipharm AB
PR-05-25-NI-01May 13, 2025
Announcement
Swarm Oncology and Cellex Cell Professionals Announce Partnership to Advance Swarm's T Cell Therapies for Solid Cancers
Cellex Cell Professionals
PR-02-25-NI-23Feb 24, 2025
Announcement
Inceptor Bio and GRIT Bio Cooperate to Advance IB-T101, a Next-Generation Solid Tumor CAR-T Utilizing the OUTLAST™ Platform
Inceptor Bio
PR-12-24-NI-142Dec 18, 2024
Changing Roles
How are Advancements in Technology Reshaping the Roles and Capabilities of CDMOs and CROs in the Drug Development Life Cycle?
Pharma's Almanac
PAO-08-24-RT-01Aug 07, 2024
CDMO Model
Rethinking the Conventional CDMO Model
Wheeler Bio
PAO-08-24-CL-04Jul 29, 2024
Regulatory
Building a Path to Approval with Effective Regulatory Support
Mira Han
Samsung Biologics
PAO-07-24-CL-12Jul 29, 2024
CDMO Selection
Why Fina Biosolutions Partnered With Scorpius BioManufacturing for cGMP Production of EcoCRM® (CRM197)
Scorpius BioManufacturing
PAO-11-23-CL-04Dec 08, 2023
Strategic Partnership
Samsung Biologics and Kurma Partners Announce Strategic Partnership for Development and Manufacturing of Biologics for Kurma’s Portfolio Companies
Samsung Biologics
PR-M10-23-06Oct 24, 2023
CDMO Partnerships
Webinar: A Developer's Guide to Partnering With the Right CDMO, Presented by Samsung Biologics
Samsung Biologics
PAO-08-23-PATV-01Aug 16, 2023
CDMO Partnerships
Why Choosing the Right CDMO Partner is Essential in Today’s Pharmaceutical Market
Daniel Buckley
Samsung Biologics
PAO-05-23-CL-07Jun 19, 2023
Strategic Partnership
Hovione and Laxxon Medical Establish an Agreement for the cGMP Production of 3D Screen Printed Pharmaceutical Applications
Hovione
PR-M03-23-06Mar 22, 2023
ADCS
Improving the Therapeutic Index of ADCs with a Peptide Linker Technology
Philipp Spycher
Araris Biotech AG
PAO-07-022-CL-01Jul 07, 2022
Cell Line Development
Wheeler Bio Integrates the Solentim® Ecosystem by Advanced Instruments to Deliver the Highest Level of Consistency Across Their Cell Line Development Workflow
Advanced Instruments
PR-M06-22-04Jun 14, 2022
Immuno-Oncology
Tuning the Myeloid Compartment with a Best-in-Class CDMO
Kiren Khanduga; Alicia Levey, Ph.D.
Pionyr Immunotherapeutics
PAO-06-022-CL-04Jun 06, 2022
Digitalization
Reducing Time to IND, Increasing Quality, and Building Trust through Shared Data
David Alvaro, Ph.D.; Christa Short; Jesse McCool, Ph.D.; Lance Johnson; Markus Gershater, Ph.D.; Michael Sokolov, Ph.D.; Yuk Chun Chiu, M.S.E.; Guy Levy-Yurista, Ph.D.; David Schmidt, M.B.A., M.Sc.
Pharma's Almanac
PAO-05-022-CL-01May 18, 2022
Chemistry
Strategic Partnerships for Pharma's Chemistry Needs
Therachem Laboratories
PAO-05-22-R250-04May 12, 2022
Strategic Partnership
DFE Pharma, Harro Höfliger, and Sterling Partner in “INTO” to Provide Formulation Services for Respiratory Products
DFE Pharma
PR-M03-22-16Mar 29, 2022
Strategic Partnership
Chimeric Partners With Be The Match BioTherapies® To Advance CHM 1101 (CLTX CAR T)
Chimeric Therapeutics
PR-M03-22-07Mar 17, 2022
Strategic Partnership
Hovione and Zerion Pharma Announce a Strategic Partnership to Market the Dispersome® Technology Platform
Hovione
PR-M02-22-19Feb 22, 2022
Strategic Partnership
eTheRNA Announces Research Agreement with Merck KGaA, Darmstadt, Germany to Access mRNA Technologies
eTheRNA Immunotherapies NV
PR-M02-22-02Feb 03, 2022